Our result also showed that NPC2 independently indicated unfavorable prognosis in glioma when adjusted for with patents’ age (p value = 0.04) and alive status (p value = 0.039) (Table 1), which revealed that NPC2 was a robust independent factor for predicting GBM survival. The gene discussed is NPC2; the disease is central nervous system cancer.